Optibrium, a leading developer of software and AI solutions for molecular design, today announced a new QuanSA™ plugin for ...
Through an international collaboration, scientists at St. Jude Children’s Research Hospital leveraged data science, pharmacology and structural information to conduct an atomic-level investigation ...
The ability to alter proteins to refine control over binding affinity and specificity can create tailored therapeutics with reduced side effects, highly sensitive diagnostic tools, efficient ...
A new plugin enables chemists to predict drug binding affinity using a visual interface, combining machine learning, and molecular modeling to improve lead optimization, and reduce experimental ...
(MEMPHIS, Tenn. – November 6, 2025) A study from St. Jude Children’s Research Hospital uncovered an alternative binding pocket within nuclear receptors, revealing a much-needed new therapy route for ...
Through an international collaboration, scientists at St. Jude Children's Research Hospital leveraged data science, pharmacology and structural information to conduct an atomic-level investigation ...
A study from St. Jude Children's Research Hospital uncovered an alternative binding pocket within nuclear receptors, revealing a much-needed new therapy route for this important class of drug targets.
Various approaches to such protein redesign have drawbacks. Traditional methods include time-consuming trial and error efforts, and many models in the emerging field ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results